This retrospective study evaluated 69 cases of metaplastic breast carcinoma (MBC), a rare and aggressive form of breast cancer, treated at a single institution. MBC typically presented with large tumors, low rates of hormone receptor expression, and a high propensity for distant metastasis. The 5-year disease-free survival (DFS) and overall
